Загрузка...
Ethics framework for treatment use of investigational drugs
BACKGROUND: Expanded access is the use of investigational drugs (IDs) outside of clinical trials. Generally it is performed in patients with serious and life-threatening diseases who cannot be treated satisfactorily with authorized drugs. Legal regulations of expanded access to IDs have been introdu...
Сохранить в:
| Опубликовано в: : | BMC Med Ethics |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672838/ https://ncbi.nlm.nih.gov/pubmed/33208140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12910-020-00560-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|